News

US FDA grants orphan drug designation to Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns to treat multiple myeloma: Paris Friday, August 1, 2025, 09:00 Hrs [IST] The US ...
P&G to invest over Rs. 2,000 crore in Gujarat for psyllium-based laxative manufacturing plant: Dr. H.G. Koshia: Shardul Nautiyal, Mumbai Friday, August 1, 2025, 08:00 Hrs [IST] In ...
US duty impact for Indian medical devices sector to be seen from relative competitiveness: AiMeD: Our Bureau, New Delhi Friday, August 1, 2025, 08:00 Hrs [IST] The industry needs ...
Karnataka issues order to merge Ayush drug dept with State FDA: Nandita Vijayasimha, Bengaluru Friday, August 1, 2025, 08:00 Hrs [IST] Karnataka government has issued order on the ...
New office-bearers elected for TN IPA, unveils ambitious plans to elevate pharmacy standards: Peethaambaran Kunnathoor, Chennai Friday, August 1, 2025, 08:00 Hrs [IST] The Tamil N ...
The Public Enterprises Selection Board (PESB) has called for applications from eligible candidates for appointment of the managing director of Public Sector Undertaking (PSU) Bengal Chemicals and ...
Cellipont & CellVax expand partnership to advance cGMP manufacturing of personalized immunotherapy FK-GI101 for GI cancers: The Woodlands, Texas Thursday, July 31, 2025, 13:00 Hrs ...
Diorasis Therapeutics & Northway Biotech partner to develop and manufacture AAV gene therapy for glaucoma: Boston, Massachusetts Thursday, July 31, 2025, 16:00 Hrs [IST] Diorasis ...
Everest Group sees Indegene as a leader in life sciences AI and analytics for commercial PEAK Matrix Assessment 2025: Our Bureau, Bengaluru Thursday, July 31, 2025, 16:15 Hrs [IST ...
Healthium Medtech appoints Rajnish Damani as group chief operating officer: Our Bureau, Bengaluru Thursday, July 31, 2025, 16:45 Hrs [IST] Healthium Medtech, a global player in me ...
Serina Therapeutics advances POZ-VMAT2i into development for tardive dyskinesia: Huntsville, Alabama Thursday, July 31, 2025, 14:00 Hrs [IST] Serina Therapeutics, Inc. (Serina), a ...
BriaCell's subsidiary, BriaPro seeks patent for immuno-oncology platform with novel multitargeting agents: Philadelphia Thursday, July 31, 2025, 17:00 Hrs [IST] BriaCell Therapeut ...